Processa Pharmaceuticals, Inc.
PCSACIK 0001533743 · last filing Jul 1, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
13,407 bought / 0 sold
net +13,407 sh · +$25.9K
- buys
- 5
- sells
- 0
- insiders active
- 5
Filing tape
Filed Wed, Jul 1, 2026
- +2,436 sh · $4.7K
Guy Wendy — Chief Administrative Officer
- Bought2,436Common Stock@ $1.93→ 14,394 held
- +2,106 sh · $4.1K
Lin Patrick — Chief Business - Strategy Off
- Bought2,106Common Stock@ $1.93→ 13,113 held
- +3,057 sh · $5.9K
Ng George K — Chief Executive Officer · Director
- Bought3,057Common Stock@ $1.93→ 15,492 held
- +3,277 sh · $6.3K
Skibsted Russell — Chief Financial Officer
- Bought3,277Common Stock@ $1.93→ 16,689 held
- +2,531 sh · $4.9K
Young David — Pres. Research & Development · Director
- Bought2,531Common Stock@ $1.93→ 21,729 held
Insiders on this tape
- Guy WendyChief Administrative Officer
- Lin PatrickChief Business - Strategy Off
- Ng George KChief Executive Officer · Director
- Skibsted RussellChief Financial Officer
- Young DavidPres. Research & Development · Director
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.